BMP4 and plasma cell myeloma: The BMP4 was biologically active, since addition of sera obtained from the AAV8‐BMP4‐treated mice to the murine myeloma cell line NS0, led to reduction in cell viability, e.g. ATP levels, and adding a BMP4‐neutralizing antibody restored viability (Fig. 2F).